Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy

類似資料

• Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa
  著者:: Kiang, Anna-Sophia, 等
  出版事項: (2020)
• Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65
  著者:: Choi, Elliot H, 等
  出版事項: (2018)
• Phenotypic expansion of autosomal dominant retinitis pigmentosa associated with the D477G mutation in RPE65
  著者:: Jauregui, Ruben, 等
  出版事項: (2020)
• A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement
  著者:: Bowne, Sara J, 等
  出版事項: (2011)
• A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement
  著者:: Bowne, Sara J, 等
  出版事項: (2011)